ADR,SEQ,ROUTE,MULTICONST,NONSERIOUS_SERIOUS_FATAL_NSF
1,1,ORAL USE,Y,S
2,1,ORAL USE,Y,N
3,1,ORAL USE,Y,N
4,1,ORAL USE,Y,S
5,1,ORAL USE,N,N
6,1,ORAL USE,Y,N
7,1,ORAL USE,Y,N
8,1,UNKNOWN,N,N
9,1,ORAL USE,Y,S
10,1,ORAL USE,Y,N
11,1,UNKNOWN,N,N
12,1,UNKNOWN,N,N
13,1,ORAL USE,N,S
14,1,ORAL USE,Y,N
15,1,UNKNOWN,N,S
16,1,ORAL USE,Y,N
17,1,ORAL USE,Y,N
18,1,ORAL USE,Y,S
19,1,UNKNOWN,N,N
20,1,UNKNOWN,N,N
21,1,ORAL USE,Y,N
22,1,ORAL USE,N,S
23,1,ORAL USE,Y,N
24,1,ORAL USE,Y,N
25,1,UNKNOWN,N,S
26,1,ORAL USE,N,N
27,1,ORAL USE,Y,S
28,1,ORAL USE,Y,S
29,1,ORAL USE,Y,N
30,1,ORAL USE,Y,N
31,1,ORAL USE,Y,N
32,1,ORAL USE,Y,N
33,1,ORAL USE,Y,N
34,1,ORAL USE,Y,N
35,1,ORAL USE,Y,N
36,1,ORAL USE,Y,S
37,1,ORAL USE,Y,S
38,1,ORAL USE,Y,N
39,1,ORAL USE,Y,S
40,1,UNKNOWN,N,N
41,1,ORAL USE,Y,N
42,1,ORAL USE,Y,S
43,1,ORAL USE,Y,S
44,1,UNKNOWN,N,N
45,1,TRANSDERMAL USE,Y,N
46,1,TRANSDERMAL USE,Y,N
47,1,UNKNOWN,N,N
48,1,ORAL USE,N,S
49,1,TRANSDERMAL USE,N,N
50,1,TRANSDERMAL USE,Y,S
51,1,TRANSDERMAL USE,Y,S
52,1,ORAL USE,Y,S
53,1,TRANSDERMAL USE,N,N
54,1,TRANSDERMAL USE,N,S
55,1,Routes with few reports,N,N
56,1,TRANSDERMAL USE,Y,N
57,1,Routes with few reports,Y,N
58,1,UNKNOWN,N,N
59,1,UNKNOWN,N,N
60,1,UNKNOWN,Y,N
